Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Labstyle Innovations Corp buy melinda

Start price
?1.59
19.09.17 / 50%
Target price
€1.94
18.10.17
Performance (%)
70.45%
End price
€2.71
18.10.17
Summary
This prediction ended on 18.10.17 with a price of €2.71. The BUY prediction by melinda for Labstyle Innovations Corp saw massive gains of 70.45%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Labstyle Innovations Corp - - - -
iShares Core DAX® -0.621% 1.080% 11.291% 16.439%
iShares Nasdaq 100 -4.503% -5.432% 22.172% 39.304%
iShares Nikkei 225® -2.562% -1.617% 7.262% 8.383%
iShares S&P 500 -1.706% -1.223% 22.550% 40.997%

Comments by melinda for this prediction

In the thread Labstyle Innovations Corp diskutieren
Prediction Buy
Perf. (%) 70.45%
Target price 1.939
Change
Ends at 18.10.17

SecteurEquipement, medizinische Versorgung und Verteilung



Firmenprofil
DarioHealth Corp. engagiert sich in der Forschung, Entwicklung und Vertrieb von pharmazeutischen Produkten. Es bietet eine Überwachungseinrichtung, eine mobile Anwendung und Datendienste für das Management von Diabetes. Es arbeitet unter der Marke Dario. Das Unternehmen wurde von Oren Fuerst, Shoshana Friedman, David Weintraub gegründet



Prediction Buy
Perf. (%) 70.45%
Target price 1.939
Change
Ends at 18.10.17

(Zielkurs erreicht)

Stopped prediction by melinda for Labstyle Innovations Corp

buy
Labstyle Innovations Corp

Start price
Target price
Perf. (%)
?2.32
18.10.17
€3.61
26.12.17
-39.23%
26.12.17